You are here: Home > Knowledge bank > News
  • German Parliament votes for UPC

    27 November 2020

    A two-thirds majority has now been established in the Bundestag for the UPC (Unified Patent Court) Agreement. As we reported in March the German Constitutional Court ruled that UPC (Unified Patent Court) ratification at that time would be unconstitutional in Germany due to the failure of the Bundestag to secure a two-thirds majority of all […]

    Read more >
  • It’s happening – Brexit – the changes you need to know

    21 October 2020

    The Brexit transition period is coming to an end on 31 December 2020 and the real effects on IP rights of the UK leaving the EU take effect from 1 January 2021. Renewals – Post Brexit there is no need to change how you interact with us to manage your IP rights renewals. Click here […]

    Read more >
  • Battery secrets – Celgard v Senior injunction

    11 August 2020

    The UK High Court has recently granted an interim injunction in a battle between two battery separator manufacturers, Celgard and Shenzhen Senior Technology Material Company (“Senior”), over accusations of the unlawful acquisition of trade secrets. The judgement can be found here. Celgard (a US manufacturer of battery separators) brought proceedings against Senior (a Chinese manufacturer […]

    Read more >
  • Is it now harder to obtain an interim injunction in the UK?

    21 July 2020

    The UK Court of Appeal has recently upheld a judgement of the UK High Court (see here), refusing an application for a preliminary injunction (see here). The case concerns two anti-insomnia drugs, Circadin and Slenyto, marketed by the claimants Neurim Pharmaceuticals and their licensee Flynn Pharma, respectively. The claimants sought interim injunctive relief to restrain […]

    Read more >
  • Neurim No More

    13 July 2020

    CJEU reverses Neurim and rejects possibility of SPCs for new therapeutic applications of previously authorised products On 9 July 2020, the Court of Justice of the European Union (CJEU) handed down its decision in Santen SAS v Directeur général de l’Institut national de la propriété industrielle (C-673/18), concluding that it is not possible to obtain […]

    Read more >
  • Regeneron Pharmaceuticals Inc v Kymab Ltd Supreme Court ruling

    26 June 2020

    The UK Supreme Court has overturned a decision from the Court of Appeal to find two of Regeneron’s transgenic mouse patents invalid for sufficiency. The effect of this judgement is that the bar on sufficiency has been returned to requiring that the disclosure of a patent supports substantially every embodiment of the claims. For the […]

    Read more >